A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation.

Abstract

INTRODUCTION:

A credible animal overactive bladder model used in basic research is an indispensable harbinger of safe and ethical clinical trials on human subjects. Our objective was to develop a new animal model of a hyperactive bladder that will be void of inflammatory urothelium lesions and display significant sensitivity to muscarinic receptor antagonists.

METHODS:

To examine the influence of 0.75% retinyl acetate solution on cystometric parameters, it was infused into the bladder for 5min. Cystometric studies with physiological saline were performed in conscious unrestrained rats 3days later. To examine the influence of retinyl acetate, acetic acid or cyclophosphamide on morphology of urinary bladders, the bladders were subjected to histopathological examination.

RESULTS:

We demonstrated that in rats subject to previous 5-minute bladder instillations with retinyl acetate, an increase of basal pressure, threshold pressure, micturition voiding pressure, bladder contraction duration, relaxation time, detrusor overactivity index, nonvoiding contraction frequency and amplitude occurs. On the other hand, a decrease in voided volume, post-void residual, volume threshold, voiding efficiency, intercontraction interval, bladder compliance and volume threshold to elicit nonvoiding contractions was observed. Administration of oxybutynin chloride (0.5mg/kg, i.v.) reversed changes of cystometric parameters evoked by retinyl acetate. Contrary to acetic acid and cyclophosphamide, bladders subjected to retinyl acetate infusion had no signs of bladder inflammation.

DISCUSSION:

The results obtained indicate that transient infusion of 0.75% retinyl acetate can induce detrusor overactivity, which is often observed in patients with overactive bladder syndrome (OAB). In addition, it was demonstrated that stimulating afferent C-fibres using retinyl acetate did not induce evident histopathological inflammatory lesions in the urinary bladder wall. It appears that in the future this model can prove useful in gaining more knowledge on the pathophysiology of OAB, and contribute to the preparation of new, more effective options of OAB pharmacotherapy.

• Authors: Andrzej Wróbel, Mirosław Łańcut, Tomasz Rechberger
• Journal: Journal of pharmacological and toxicological methods (J Pharmacol Toxicol Methods) 2015 Jul-Aug Vol. 74 Pg. 7-16 ISSN: 1873-488X [Electronic] United States
• PMID: 25957030 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 Elsevier Inc. All rights reserved.

Chemical References

• Diterpenes
• Mandelic Acids
• Muscarinic Antagonists
• Retinyl Esters
• Vitamin A
• retinol acetate
• Cyclophosphamide
• oxybutynin
• Acetic Acid

Topics

• Acetic Acid (administration & dosage)
• Administration, Intravesical
• Animals
• Consciousness (physiology)
• Cyclophosphamide (administration & dosage)
• Disease Models, Animal
• Diterpenes
• Female
• Mandelic Acids (administration & dosage)
• Muscarinic Antagonists (pharmacology)
• Rats
• Rats, Wistar
• Retinyl Esters
• Urinary Bladder (drug effects)
• Urinary Bladder, Overactive (chemically induced)
• Urination (drug effects, physiology)
• Vitamin A (administration & dosage, analogs & derivatives)